Axiogenesis is a British Company that specializes in in-vitro differentiated cells derived from murine and human stem cells. The company develops and commercializes stem cell-derived, in vitro differentiated cardiomyocytes, neurons and other cell types, as well as drug development assays and disease models. Their purpose is to help researchers discover cures for various diseases. These innovative and proprietary cell types and assays accelerate and improve drug candidate selection, lower costs and thus increase overall drug development efficiency. Axiogenesis not only provides cells and culture media but can also perform in-house tests on behalf of clients.

In vitro pharmacology

Primary Industry

Primary Office
Nattermannallee 1, Building S20
50829 Cologne